Clinical utility study of confirms mdx for prostate cancer in a community urology practice.

被引:6
|
作者
Yonover, Paul
Steyaert, Sandra
Cohen, Justin J.
Ruiz, Celeste
Grafczynska, Karolina
Garcia, Elizabeth
DeHart, Jessica
Brawer, Michael
Groskopf, Jack
Van Criekinge, Wim
机构
[1] UroPartners, Chicago, IL USA
[2] MDxHealth Inc, Irvine, CA USA
[3] Univ Ghent, Math Modeling Stat & Bioinformat, Ghent, Belgium
关键词
D O I
10.1200/JCO.2019.37.7_suppl.94
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
94
引用
收藏
页数:1
相关论文
共 50 条
  • [31] GENOMICS OF PROSTATE CANCER: CLINICAL UTILITY AND CHALLENGES
    Samija, Ivan
    Frobe, Ana
    ACTA CLINICA CROATICA, 2022, 61 : 86 - 91
  • [32] Clinical Utility of Biomarkers in Localized Prostate Cancer
    Michael S. Leapman
    Hao G. Nguyen
    Matthew R. Cooperberg
    Current Oncology Reports, 2016, 18
  • [33] A Review on the Clinical Utility of PSA in Cancer Prostate
    Mohan Adhyam
    Anish Kumar Gupta
    Indian Journal of Surgical Oncology, 2012, 3 (2) : 120 - 129
  • [34] Validation and clinical utility of prostate cancer biomarkers
    Howard I. Scher
    Michael J. Morris
    Steven Larson
    Glenn Heller
    Nature Reviews Clinical Oncology, 2013, 10 : 225 - 234
  • [35] A Review on the Clinical Utility of PSA Cancer Prostate
    Adhyam, Mohan
    Gupta, Anish Kumar
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2012, 3 (02) : 120 - 129
  • [36] Validation and clinical utility of prostate cancer biomarkers
    Scher, Howard I.
    Morris, Michael J.
    Larson, Steven
    Heller, Glenn
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (04) : 225 - 234
  • [37] Clinical Utility of Biomarkers in Localized Prostate Cancer
    Leapman, Michael S.
    Nguyen, Hao G.
    Cooperberg, Matthew R.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (05)
  • [38] Study evidence confirms current clinical practice in refractory metastatic colorectal cancer: the ReDOS trial
    Hofheinz, Ralf-Dieter
    Stintzing, Sebastian
    LANCET ONCOLOGY, 2019, 20 (08): : 1036 - 1037
  • [39] Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics
    Eccles, DM
    ANNALS OF ONCOLOGY, 2004, 15 : 133 - 138
  • [40] Implementation of the S3 prostate cancer guideline in daily clinical practice. Results of a survey among urologists
    Froehner, M.
    Khan, C.
    Koch, R.
    Schorr, S. G.
    Wirth, M.
    UROLOGE, 2014, 53 (10): : 1500 - 1503